Monsanto (NYSE:MON) retained its buy rating from UBS Securities (NYSE:UBS), as analyst Don Carson kept it the same, while also retaining his price targe of $83 a share, down from his previous $86 a share.
Most analysts, including Carson, look at Monsanto's Roundup herbicide as unable to improve its price, not because of generic versions from China, but from their major competitors like Dow Chemical (NYSE:DOW) and Syngenta AG (NYSE:SYT).
Carson also reduced the earnings per share for Monsanto for the current fiscal year from $3.10 to $3.00, ending in August 2010; down from $3.95 to $3.65 for fiscal 2011; and from $4.85 to $4.40 for fiscal 2012.
No comments:
Post a Comment